SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Dauntless who wrote (5461)9/3/1998 11:55:00 PM
From: Ron Sigourney  Respond to of 7041
 
AMEN....



To: Dauntless who wrote (5461)9/4/1998 1:58:00 AM
From: Bill Wexler  Respond to of 7041
 
Clueless - you forgot the most important one of all:

Some said (over & over)...
Zonagen will NEVER return to its 52 week low - it did.

I was 100% correct about the TXB fraud.
I am 100% correct about the Zonagen fraud.

Zonagen is a fraud and a scam.



To: Dauntless who wrote (5461)9/4/1998 2:10:00 AM
From: Bill Wexler  Read Replies (1) | Respond to of 7041
 
The Zonagen (ZONA)/Texas Biotech (TXB) circle jerk.

David McWilliams, president of a bizarre, worthless company called Texas Biotechnology Corporation (TXB), sits on Zonagen's board.

It is extremely interesting to note that TXB's capitalization structure has amazing parallels to Zonagen. Just like Zonagen's fortuitous deal with Scering-plough, TXB also has a licensing deal with a reputable firm - SmithKline, who also happens to be an early investor.

sec.yahoo.com

We all know that fine companies like ZONA and TXB are more concerned with advancing modern medicine than lining their pockets. We can rest assured that they wouldn't resort to dealing with Wall Street bottom feeders......right?

worth.com